| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |